MyMSTeam

Great question! Ocrevus Zunovo is the newer, injectable version of Ocrevus, approved in September 2024. Instead of a lengthy IV infusion at a specialized infusion center, it's a quick 10-minute injection given under the skin — twice a year, just like the original.

Here's a quick comparison to help think it through:

- Show Full Answer

Great question! Ocrevus Zunovo is the newer, injectable version of Ocrevus, approved in September 2024. Instead of a lengthy IV infusion at a specialized infusion center, it's a quick 10-minute injection given under the skin — twice a year, just like the original.

Here's a quick comparison to help think it through:

- Original Ocrevus: IV infusion, at least 2 hours per visit, requires a specialized infusion center
- Ocrevus Zunovo: 10-minute subcutaneous (under-skin) injection, given at a regular doctor's office or clinic

The good news is that clinical trials showed Ocrevus Zunovo is just as effective as the IV version, suppressing relapses and new lesions by 97% over 48 weeks. Whether it's worth switching really depends on personal circumstances. It could be a great option if:

- Long infusion appointments are difficult to manage
- There's no easy access to a specialized infusion center
- A quicker, more flexible option is preferred

Many MyMSTeam members on the original Ocrevus have mentioned planning low-energy days around infusions, partly due to pre-medication like Benadryl causing fatigue. A shorter appointment could make that easier to manage.

That said, it's always best to chat with a neurologist before making any changes to a treatment plan, as they can weigh in on what makes the most sense individually.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

FDA Approves 10-Minute Injectable Version of Ocrevus

7 Tips To Help Prevent MS Infusion Side Effects